Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.
Späth PJ, Schneider C, von Gunten S. Späth PJ, et al. Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):215-231. doi: 10.1007/s00005-016-0422-x. Epub 2016 Sep 16. Arch Immunol Ther Exp (Warsz). 2017. PMID: 27638480 Review.
Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies.
Sudo M, Miyaji K, Späth PJ, Morita-Matsumoto K, Yamaguchi Y, Yuki N. Sudo M, et al. Among authors: spath pj. Int Immunopharmacol. 2016 Nov;40:11-15. doi: 10.1016/j.intimp.2016.08.019. Epub 2016 Aug 24. Int Immunopharmacol. 2016. PMID: 27567246
On the dark side of therapies with immunoglobulin concentrates: the adverse events.
Späth PJ, Granata G, La Marra F, Kuijpers TW, Quinti I. Späth PJ, et al. Front Immunol. 2015 Feb 5;6:11. doi: 10.3389/fimmu.2015.00011. eCollection 2015. Front Immunol. 2015. PMID: 25699039 Free PMC article. Review.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Kerr J, Quinti I, Eibl M, Chapel H, Späth PJ, Sewell WA, Salama A, van Schaik IN, Kuijpers TW, Peter HH. Kerr J, et al. Among authors: spath pj. Front Immunol. 2014 Dec 12;5:629. doi: 10.3389/fimmu.2014.00629. eCollection 2014. Front Immunol. 2014. PMID: 25566244 Free PMC article. Review.
Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition.
Sudo M, Yamaguchi Y, Späth PJ, Matsumoto-Morita K, Ong BK, Shahrizaila N, Yuki N. Sudo M, et al. Among authors: spath pj. PLoS One. 2014 Sep 26;9(9):e107772. doi: 10.1371/journal.pone.0107772. eCollection 2014. PLoS One. 2014. PMID: 25259950 Free PMC article.
A novel use of intravenous immunoglobulin is not restricted to complement hypercatabolism because of factor H deficiency.
Späth PJ. Späth PJ. Prog Transplant. 2014 Jun;24(2):120. doi: 10.7182/pit2014750. Prog Transplant. 2014. PMID: 24919726 No abstract available.
Immunoglobulin g for the treatment of chronic pain: report of an expert workshop.
Tamburin S, Borg K, Caro XJ, Jann S, Clark AJ, Magrinelli F, Sobue G, Werhagen L, Zanette G, Koike H, Späth PJ, Vincent A, Goebel A. Tamburin S, et al. Among authors: spath pj. Pain Med. 2014 Jul;15(7):1072-82. doi: 10.1111/pme.12319. Epub 2014 Jan 14. Pain Med. 2014. PMID: 24422915
Naturally occurring antibodies/autoantibodies in polyclonal immunoglobulin concentrates.
Späth PJ, Lutz HU. Späth PJ, et al. Adv Exp Med Biol. 2012;750:239-61. doi: 10.1007/978-1-4614-3461-0_18. Adv Exp Med Biol. 2012. PMID: 22903679 Review.
Will immunoglobulin therapy of autoimmune blistering skin diseases survive the new financial management of inpatients?
Späth PJ, Hunziker T. Späth PJ, et al. Dermatology. 2011;222(2):138-9. doi: 10.1159/000323006. Epub 2011 Jan 12. Dermatology. 2011. PMID: 21228555 Free article. No abstract available.
IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy.
Yuki N, Watanabe H, Nakajima T, Späth PJ. Yuki N, et al. Among authors: spath pj. J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):87-91. doi: 10.1136/jnnp.2010.205856. Epub 2010 Jul 28. J Neurol Neurosurg Psychiatry. 2011. PMID: 20667861
61 results
Jump to page